19-54818366-G-A
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_013289.4(KIR3DL1):c.122G>A(p.Arg41Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000679 in 1,605,618 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_013289.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KIR3DL1 | NM_013289.4 | c.122G>A | p.Arg41Gln | missense_variant | 3/9 | ENST00000391728.8 | NP_037421.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KIR3DL1 | ENST00000391728.8 | c.122G>A | p.Arg41Gln | missense_variant | 3/9 | 1 | NM_013289.4 | ENSP00000375608 | P2 | |
KIR3DL1 | ENST00000326542.11 | c.122G>A | p.Arg41Gln | missense_variant | 3/8 | 1 | ENSP00000326868 | A2 | ||
KIR3DL1 | ENST00000358178.4 | c.70+797G>A | intron_variant | 1 | ENSP00000350901 |
Frequencies
GnomAD3 genomes AF: 0.000116 AC: 17AN: 146278Hom.: 0 Cov.: 25
GnomAD3 exomes AF: 0.0000520 AC: 12AN: 230880Hom.: 3 AF XY: 0.0000401 AC XY: 5AN XY: 124552
GnomAD4 exome AF: 0.0000630 AC: 92AN: 1459232Hom.: 2 Cov.: 45 AF XY: 0.0000565 AC XY: 41AN XY: 725928
GnomAD4 genome AF: 0.000116 AC: 17AN: 146386Hom.: 0 Cov.: 25 AF XY: 0.000126 AC XY: 9AN XY: 71340
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 02, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at